Certara, Inc. Common Stock (CERT) is a publicly traded Healthcare sector company. As of May 21, 2026, CERT trades at $4.67 with a market cap of $709.37M and a P/E ratio of -46.45. CERT moved +1.63% today. Year to date, CERT is -48.34%; over the trailing twelve months it is -60.05%. Its 52-week range spans $4.45 to $15.69. Analyst consensus is buy with an average price target of $8.06. Rallies surfaces CERT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Certara Q1 revenue rises 1% to $106.9M; net loss widens to $8.8M: Certara’s Q1 revenue grew 1% to $106.9 million, driven by a 7% rise in software sales to $49.7 million while services revenue fell 4% to $57.2 million. The company reported an $8.8 million net loss versus $4.7 million net income last year and lowered 2026 revenue growth guidance to 0%-4% excluding its divested writing unit.
| Metric | Value |
|---|---|
| Price | $4.67 |
| Market Cap | $709.37M |
| P/E Ratio | -46.45 |
| EPS | $-0.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.69 |
| 52-Week Low | $4.45 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $419.75M |
| Net Income | $-15.10M |
| Gross Margin | 0.00% |
10 analysts cover CERT: 0 strong buy, 4 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.06.